UK markets close in 2 hours 22 minutes

Oncopeptides AB (publ) (0RN4.IL)

IOB - IOB Delayed price. Currency in SEK
Add to watchlist
2.8350-0.3275 (-10.36%)
As of 04:24PM BST. Market open.
Full screen
Previous close3.1625
Open0.0000
Bid3.3250 x N/A
Ask3.7400 x N/A
Day's range2.8350 - 2.8350
52-week range2.8050 - 10.5400
Volume26,104
Avg. volume17,080
Market cap290.749M
Beta (5Y monthly)-0.66
PE ratio (TTM)N/A
EPS (TTM)-3.3900
Earnings date14 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

    DUBAI, United Arab Emirates and STOCKHOLM, Sweden, March 27, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO (“Vector”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in the Middle East and North Africa (“MENA”) countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq. Under the terms of this e